Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
about
Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a reviewSerum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPDIs periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?The role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema.Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study.Concomitant elevations of MMP-9, NGAL, proMMP-9/NGAL and neutrophil elastase in serum of smokers with chronic obstructive pulmonary disease.FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure.MMP-9 cleaves SP-D and abrogates its innate immune functions in vitroADAM17 mediates MMP9 expression in lung epithelial cells.A gender difference in circulating neutrophils in malnourished patients with COPD.Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.Matrix metalloproteinase-9 predicts pulmonary status declines in α1-antitrypsin deficiency.Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO.COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts.Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD SmokersAdipokine CTRP-5 as a Potential Novel Inflammatory Biomarker in Chronic Obstructive Pulmonary DiseaseIncreased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD.Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.Blood fibrinogen as a biomarker of chronic obstructive pulmonary diseaseAssociation of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study.Multiple Circulating Cytokines Are Coelevated in Chronic Obstructive Pulmonary Disease.Increased serum ox-LDL levels correlated with lung function, inflammation, and oxidative stress in COPDEffects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.The aging immune system and its relationship to the development of chronic obstructive pulmonary disease.Effect of Quanzhenyiqitang on apoptosis of alveolar macrophages and expression of histone deacetylase 2 in rats with chronic obstructive pulmonary disease.Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.Matrix Metalloproteinases and Their Inhibitors in Chronic Obstructive Pulmonary Disease.Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease.Relationship of serum levels of interleukin 6, interleukin 8, and C-reactive protein with forced expiratory volume in first second in patients with mustard lung and chronic obstructive pulmonary diseases: systematic review and meta-analysisMMP-8, MMP-9 and Neutrophil Elastase in Peripheral Blood and Exhaled Breath Condensate in COPD.Sputum neutrophils are elevated in smelter workers, and systemic neutrophils are associated with rapid decline in FEV1.Free Urinary Desmosine and Isodesmosine as COPD Biomarkers: The Relevance of Confounding Factors.Interrelationship of circulating matrix metalloproteinase-9, TNF-α, and OPG/RANK/RANKL systems in COPD patients with osteoporosis.Matrix metalloproteinases -8 and -9 in the Airways, Blood and Urine During Exacerbations of COPD.Periodontal health and serum, saliva matrix metalloproteinases in patients with mild chronic obstructive pulmonary disease.End-of-life prognostic indicators in patients with COPD: Part 1.Associations of pulmonary function with serum biomarkers and dialysis adequacy in patients undergoing peritoneal dialysis.
P2860
Q28390078-B59972A7-1664-41AF-AF8B-B52F88856F06Q30925905-E3168844-0E4A-4014-9649-F7120F3AEED6Q33612752-D676A29B-B7B7-4DD6-923B-FFF2E114EC03Q33649907-8B48E82F-A46A-4002-A18D-A63D9D067CC1Q33740494-18566300-CD58-4072-96FF-07A2DD44F161Q33803872-B9D48B5F-0F01-4919-9A28-87012F44C97EQ33844617-2F37A6D6-B2F8-4191-A600-CF699BA9934DQ33863052-9B796127-A7F3-4C29-9068-705D29CFBC8EQ34364261-251C1895-24DE-4E07-A1EF-B6BB6C5B01FCQ34558156-5605F537-0150-44BE-96A1-63FD7BEA2584Q34621067-E82EA40A-45C8-45FB-AB36-B27AAAA11CA6Q34636461-1F2CBE9D-9E49-4476-A013-032042E48474Q34778477-8BD1567A-DCDE-4567-938B-AE0836EFC325Q35031693-C2B92A00-2EB7-4E61-86F0-0416DF0CF866Q35637295-F4E54D0E-3136-4861-9D8C-5397F82189B9Q35822156-46212906-6603-42AE-91B2-D38FA5BD4CF5Q35870656-F7784BA3-FC3C-476D-8DF4-5F677C8CE3A8Q36194869-C6DB1390-7363-46E5-882D-5C22EA28F357Q36277943-759EA64B-5688-424A-886A-050874F4D5E9Q36383938-A95C5B84-B5F8-41DC-9DD0-FDC4BD1DA5D1Q36961473-0D5386F3-652B-4638-B630-B6416A0D76AAQ37012728-91AD6027-2D80-4304-B768-18899F4A026AQ37113883-D2BCBC4C-41B9-4763-8137-B35E9303BDABQ37156936-B67DB5CE-E98B-4E1A-BDCE-E6D512841A6DQ37173995-22BF4E70-0A74-4412-93D7-2B2365F56365Q37636173-AE60A566-F4CF-4CD1-BAA5-D2787DAF3197Q37637719-411023BD-5CD9-4AF1-85D8-4849E61C477AQ37710015-8BDB2EF7-BA47-411E-91CC-7D6F318294C9Q38056532-50C8D964-AA70-48EA-88D4-C6EF47176FF8Q38649641-878559CE-ADAC-42DC-93F3-AEC9BA14F751Q38710985-B1DD28EA-C907-4145-9D95-6323165A8F82Q39410233-6C70A0F1-7804-403C-84F8-B8165F5FC7C3Q40438411-CD9CBC12-FB58-46EA-ABAA-5E2F42E6EED0Q40814087-C0053643-70A1-486E-9300-E2C6F15D99EAQ41434441-1286C569-620F-48C7-9579-67730066D182Q43955644-D5145332-304F-4B38-A700-93E7329E1CD4Q46662378-E9B18EC8-38B5-4509-B996-7B1815B9E8C5Q50912524-3142D5A7-61F1-4830-9A87-5DFC4B418D60Q51428161-68B99BED-86F1-4E0A-A2A5-74B9F34733C0Q51547824-FA407C89-5F30-4A45-AF78-E9E0AEA8DB03
P2860
Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Serum biomarkers as predictors ...... obstructive pulmonary disease.
@en
Serum biomarkers as predictors ...... obstructive pulmonary disease.
@nl
type
label
Serum biomarkers as predictors ...... obstructive pulmonary disease.
@en
Serum biomarkers as predictors ...... obstructive pulmonary disease.
@nl
prefLabel
Serum biomarkers as predictors ...... obstructive pulmonary disease.
@en
Serum biomarkers as predictors ...... obstructive pulmonary disease.
@nl
P2093
P1433
P1476
Serum biomarkers as predictors ...... obstructive pulmonary disease.
@en
P2093
Hiroaki Satoh
Kanji Fukuda
Morihiro Okada
Takuya Iwata
Yuji Higashimoto
Yuji Tohda
P304
P356
10.1016/J.RMED.2009.01.021
P577
2009-02-26T00:00:00Z